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Abstract: Accurate DNA replication is crucial for cell survival and the maintenance of genome
stability. Cells have developed mechanisms to cope with the frequent genotoxic injuries that arise
from both endogenous and environmental sources. Lesions encountered during DNA replication
are often tolerated by post-replication repair mechanisms that prevent replication fork collapse and
avert the formation of DNA double strand breaks. There are two predominant post-replication repair
pathways, trans-lesion synthesis (TLS) and template switching (TS). TLS is a DNA damage-tolerant
and low-fidelity mode of DNA synthesis that utilizes specialized ‘Y-family’ DNA polymerases to
replicate damaged templates. TS, however, is an error-free ‘DNA damage avoidance’ mode of
DNA synthesis that uses a newly synthesized sister chromatid as a template in lieu of the damaged
parent strand. Both TLS and TS pathways are tightly controlled signaling cascades that integrate
DNA synthesis with the overall DNA damage response and are thus crucial for genome stability.
This review will cover the current knowledge of the primary mediators of post-replication repair and
how they are regulated in the cell.
Keywords: DNA damage tolerance; post replication repair; DNA damage response; trans-lesion
synthesis; template switching
1. Introduction
Accurate and efficient DNA replication is crucial for the health and survival of all living organisms.
Under optimal conditions, the replicative DNA polymerases ε, δ, and α can work in concert to ensure
that the genome is replicated efficiently with high accuracy in every cell cycle [1]. However, DNA is
constantly challenged by exogenous and endogenous genotoxic threats, including solar ultraviolet
(UV) radiation and reactive oxygen species (ROS) generated as a byproduct of cellular metabolism.
Damaged DNA can act as a steric block to replicative polymerases, thereby leading to incomplete
DNA replication or the formation of secondary DNA strand breaks at the sites of replication stalling.
Incomplete DNA synthesis and DNA strand breaks are both potential sources of genomic instability [2].
As discussed elsewhere in this special issue, an arsenal of DNA repair mechanisms exists to repair
various forms of damaged DNA and minimize genomic instability. Most DNA repair mechanisms
require an intact DNA strand as template to fix the damaged strand. In this review, we will discuss the
mechanisms behind Post-Replication Repair (PRR) that specifically help cells tolerate damage on the
single stranded DNA template.
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2. DNA Damage Repair and Complications at the Replication Fork
DNA damage can be categorized by structural changes in the DNA such as base alteration, single
stranded break (SSB), and double stranded break (DSB), each repaired via a distinct mechanism [3].
As summarized in Figure 1, a broad spectrum of DNA repair mechanisms has evolved to remove
lesions that occur on double stranded DNA. Most DNA repair mechanisms rely on information from
an undamaged DNA strand, either the complementary strand of the double helix (nucleotide excision
repair (NER), base excision repair (BER) and SSB repair) or the sister chromatid and homologous allele
(homologous recombination). Utilizing an undamaged template prevents aberrant alteration of the
genetic coding on the damaged DNA strand. A major limitation to template-based repair mechanisms
is that sometimes an undamaged DNA template strand is unavailable. This problem is frequently
encountered during DNA replication, in the synthesis (S) phase of the cell cycle.
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DNA. The gap left behind is then filled by a DNA polymerase. Single stranded breaks (SSBs) are 
recognized by poly(ADP-ribose) polymerase 1 (PARP1), which activates downstream signaling that 
leads to gap-filling by DNA polymerases. Double stranded breaks (DSBs) are repaired by end joining 
(EJ) or by homologous recombination (HR). EJ directly ligates the exposed DSB with DNA ligase, 
while, during HR, break sites are replicated using undamaged homologous sequences of sister 
Figure 1. Many mechanisms efficiently repair DNA damage on the DNA double helix. Lesions in
the double stranded DNA can be efficiently repaired by mechanisms corresponding to the specific
type of DNA damage. Base-specific damage can be directly reversed by particular enzymes such as
photolyases and O6-methylguanine DNA methyltransferase (MGMT) (reviewed in [4]). The majority
of base-specific damage is repaired by base excision repair (BER) and nucleotide excision repair (NER).
In BER and NER, the damage base or surrounding DNA is excised from th double stranded DNA.
The gap left behind is then filled by a DNA polymerase. Single stranded breaks (SSBs) re recognized
by poly(ADP-ribose) polymerase 1 (PARP1), which activates downstream signaling that leads to
gap-filling by DNA polymerases. Double stranded breaks (DSBs) are repaired by end joining (EJ)
or by homologous recombination (HR). EJ directly ligates the exposed DSB with DNA ligase, while,
during HR, break sites are replicated using undamaged homologous sequences of sister chromatid
templates. In contrast, DNA lesions in single stranded DNA (ssDNA) cannot be repaired by BER,
NER, HR, or EJ and must be remediated using alternative mechanisms (as suggested by the question
mark in the figure). Post replication repair is a mechanism specialized in tolerating lesions in single
stranded template.
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DNA replication is a multistep process with two key events; (1) unwinding of the annealed
double helix to expose ssDNA and (2) using this ssDNA as template to synthesize daughter strands.
During an unperturbed S phase, DNA unwinding, carried out by the replicative helicase (the
CDC45-MCM2-7-GINS or “CMG” complex), is strictly coupled with polymerase activity at replication
forks (reviewed in [5]). Three replicative polymerases, pol ε on the leading strand and pol δ and pol
α on the lagging strand, copy the template DNA with an error rate less than 10−4 [1]. The compact
catalytic sites of replicative DNA polymerases confer high fidelity but preclude DNA damage-tolerant
synthesis when using templates harboring bulky DNA lesions. As a result, replicative polymerases
stall when a lesion is encountered (Figure 2). Fork-stalling DNA lesions are very prevalent in cells.
In the human body there are approximately 30,000 lesions in every cell at any given time due to aerobic
metabolism and endogenous depurination and deamination events [6]. It is inevitable that replication
forks will be challenged by fork stalling lesions during DNA synthesis. Lesions encountered at
replicating DNA are unique because the DNA in the vicinity of a replication fork is not double-helical.
Excising the lesion from the ssDNA, as seen in BER and NER, will generate DNA strand breaks and
result in fork collapse.
To survive fork-stalling DNA lesions, cells have developed post replication DNA repair
mechanisms (PRR), which allow replication forks to progress through the lesions on damaged
templates. The main role of PRR is to “patch” ssDNA gaps in the daughter strand and restore DNA to
its double-stranded state for subsequent DNA repair via other mechanisms (covered in Figures 2 and 3
and later sections of the paper). There are two mechanisms of PRR; trans-lesion synthesis (TLS), which
employs TLS polymerases to directly replicate across the DNA lesion [7], and template switching (TS),
which “borrows” the genetic information from the newly synthesized sister chromatid as a replication
template [8] and thus avoids the lesion (Figure 3). As described in detail below, the TLS and TS
pathways are coordinated to facilitate ongoing DNA synthesis on damaged genomes.
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Figure 2. DNA lesions in single stranded DNA (ssDNA) are detrimental to the replication fork. DNA
lesions on an ssDNA template act as road blocks for replicative polymerases but not for the replicative
DNA helicase. An uncoupling of replicative DNA polymerase and DNA helicase activities generates
single stranded DNA tracts. Persistent ssDNA is fragile and prone to breakage, generating lethal DSB.
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PCNA mono-ubiquitination has been observed in both Rad18−/− DT40 cells and in Rad18 KO mice,
suggesting other E3 ubiquitin ligases may use PCNA as a substrate [32–34].
PCNA K164 mono-ubiquitination can be further extended to K63-linked poly-ubiquitin chains
by another E3 ubiquitin-ligase, which in yeast is Rad5 [14]. The interaction between Rad18 and
Rad5 brings Ubc13/Mms2-Rad5 to the vicinity of stalled replication forks [35]. Ubc13/Mms2 and
Rad5-mediated poly-ubiquitination of PCNA directs lesion avoidance using the TS pathway [36].
In Xenopus laevis, PCNA poly-ubiquitination is induced by DNA damage, although it is unclear why
PCNA is also modified when replicating undamaged DNA in this system [37]. In humans, the two
human Rad5 orthologues, SNF2 histone-linker PHD-finger RING-finger helicase (SHPRH) [38,39] and
helicase-like transcription factor (HLTF) [40,41], mediate PCNA poly-ubiquitination. Although PCNA
poly-ubiquitination is a less abundant modification than PCNA mono-ubiquitination [42], it is clear
that the human RAD5 homologues do contribute to DNA damage tolerance [43]. There are also some
studies suggesting that Rad5 has an Mms2-Ubc13-independent role in the TLS pathway [44–46].
SUMOylation of PCNA, catalyzed by UBC9 and Siz1/2, has also been observed on lysines
K127 and/or K164 during normal DNA replication or following sub-lethal DNA-damaging
treatments [14,15]. SUMOylated PCNA interacts with Srs2, a helicase that displaces the Rad51
recombinase from ssDNA. Since Rad51 is essential for DNA repair via homologous recombination,
Rad51 displacement prevents recombinational repair [47,48]. Consequently, the inhibition of
homologous recombination by Srs2 at the replication fork further limits the pathway choices to
PRR when a DNA lesion is encountered on the single stranded template [49]. Interestingly, PCNA
SUMOylation also has been shown to facilitate Rad18 E3 ligase activity towards PCNA by physically
linking Rad18 and PCNA in yeast [50]. Although this is not an evolutionally conserved mechanism for
Rad18 activation, it still exemplifies the cross talk between different PCNA modifications.
4. Trans-Lesion Synthesis
The Trans-Lesion Synthesis branch of PRR employs specialized DNA polymerases to perform
replicative bypass of DNA lesions. In a process termed “polymerase switching” the TLS polymerases
are recruited to stalled replication forks where they transiently replace the replicative polymerases.
There are three TLS polymerases RAD30 (η), Rev1, and ζ, in budding yeast and two additional TLS
polymerases, κ and ι, in vertebrates. Of these TLS polymerases, η, κ, ι, and Rev1 belong to the Y-family,
while Pol ζ belongs to the B family [51]. The unique structure of TLS polymerases allows them to
synthesize across lesions that block the conventional replicative polymerases. Compared to replicative
polymerases, TLS polymerases have larger catalytic sites that are able to make loose contact with the
template DNA and incoming nucleotide. This structure makes TLS polymerases more promiscuous
in their selection of template DNA and allows them to accommodate templates with bulky adducts
and abasic sites [52]. Furthermore, TLS polymerases lack the proofreading exonuclease domain that is
present in the replicative ones and which is critical for accurate DNA synthesis. Therefore, utilizing
TLS polymerases to replicate damaged templates can confer damage-tolerant DNA synthesis at the
cost of reduced replication accuracy [7].
Although TLS polymerases are inherently error prone, TLS can be relatively error-free in instances
when the “correct” Y-family polymerase(s) are recruited to bypass a cognate lesion. For example,
in the presence of a UV radiation-induced thymine-thymine cis-syn cyclobutane dimer (CPD),
DNA Pol η preferentially incorporates two adenines (A) opposite the thymine-thymine dimer
to accurately bypass the lesion [53]. Similarly, Pol κ accurately bypasses bulky (BP)-7,8-diol-9,
10-epoxide-N(2)-deoxyguanosine (BPDE-dG) adducts induced by the environmental carcinogen
Benzo[a]pyrene [54,55]. Moreover, Pol ι frequently incorporates a correct base (cytosine, C) following
the oxidative lesion 8-oxoguanine as well as 2-Acetylaminofluorene (AAF) adducted guanine [56].
Thus TLS polymerases are capable of contributing to DNA damage tolerance and S-phase progression
without compromising genome stability.
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Due to the intrinsic ability of TLS polymerases to accommodate a wide variety of lesions,
sometimes lesion bypass can be carried out by a “non-ideal” error-prone polymerase, especially
when the “correct” polymerase is not available. This phenomenon of compensatory error-prone lesion
bypass by inappropriate DNA polymerases is exemplified by xeroderma pigmentosum variant (XP-V)
patients, in which Pol η is mutated [57]. XP-V patients experience extreme sunlight sensitivity and have
an increased incidence of skin cancer. In XP-V patients, UV-induced DNA damage is bypassed by other
Y-family DNA polymerases such as Pol ι [58] and Pol κ [59], resulting in high mutation rates. These
studies suggest that, despite the presence of intact nucleotide excision repair, selecting the correct TLS
polymerase to accurately bypass the DNA lesion is crucial for the prevention of elevated mutagenesis.
As mentioned previously, the recruitment of TLS polymerases to stalled replication forks is
facilitated by Rad18-mediated PCNA mono-ubiquitination. TLS polymerases possess a higher
affinity towards PCNA in its mono-ubiquinated state [20,21] and may displace the processive DNA
polymerases to replicate through damaged DNA [60]. Interestingly, lysine 164 of PCNA is not located
at the IDCL, the protein-protein interacting domain on PCNA that mediates the interaction with the PIP
motif of target proteins [13]. Instead, the K164-linked ubiquitin is attached to the back face of PCNA,
creating a distinct interacting motif for TLS polymerases [22] (Figure 4). In addition to a PIP-motif, all
Y family polymerases contain at least one Ubiquitin-Binding Zinc finger (UBZ) or Ubiquitin-Binding
Motif (UBM) at the C-terminus of the protein [61]. The ubiquitin-binding domain, together with the
PIP motif on TLS polymerases, mediates the preferential interaction with mono-ubiquitinated PCNA.
In this structure, the binding of Pol η to PCNA does not interfere with the binding of Pol δ. Instead, Pol
η is resting at the back face of PCNA, while Pol δ is contacting the front surface of PCNA [22] (Figure 4).
It is important to note that PCNA is a trimeric ring, which in theory could interact with three DNA
polymerases at the same time. In fact, the structural study by Freudenthal et al. favors the notion
that the PCNA ring acts as a molecular ‘tool belt’, carrying both TLS and replicative polymerases to
cope with damage on ssDNA, similar to the β sliding clamp in E.coli [62]. Unlike the Y-family TLS
polymerases (η, κ, ι, REV1), Pol ζ (a B-family DNA polymerase) does not contain a UBZ domain.
However, Pol ζ recruitment to stalled replication forks is mediated by the Y family polymerases,
such as REV1 [63], and therefore might have some dependency on PCNA mono-ubiquitination.
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inter-domain connecting loop (IDCL). Ubiquiti n in red. Three ind vidual PCNA mol cules
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Despite the extensive studies suggesting that PCNA and its ubiquitination facilitate TLS activation,
the absolute requirement of PCNA mono-ubiquitination is still being debated. Several lines of evidence
suggest that TLS can, in some instances, proceed without the need for PCNA mono-ubiquitination.
Gueranger and collegues showed that the Pol η PIP-box mutant could completely restore the UV
resistance in a pol η-deficient cell line [64]. Acharya and colleagues additionally found that the
ubiquitin-binding domain of pol η is dispensable for its TLS function [65,66]. Embryonic fibroblasts
from a genetically-engineered PCNA K164R “knock-in” mouse show some attenuation of TLS activity,
yet retain lesion bypass activity [67]. In a recent study, pol ηwas shown to interact with unmodified
and mono-ubiquitinated PCNA with equivalent affinities in vitro. Furthermore, mono-ubiquitinated
PCNA did not enhance the lesion bypass activity of pol η [68]. Together, these studies suggest that
PCNA ubiquitination is important for high-capacity TLS and efficient recruitment of TLS polymerases
in normal cells. However, TLS may also occur in the absence of PCNA mono-ubiquitination, most
likely due to residual UBZ-independent interactions between PCNA and the PIP motifs.
Even with our mechanistic understanding of trans-lesion synthesis, it is still not known how cells
recruit appropriate and specific TLS polymerases to their cognate DNA lesions. It is formally possible
that unknown factors “read” the structure of distorted DNA and then signal for the recruitment of the
specific polymerases. However, as clearly documented in XP-V cells, CPD lesions can be bypassed by
non-cognate TLS polymerases when Pol η is absent. Therefore, it is possible that mono-ubiquitinated
PCNA does not discriminate between different TLS polymerases and serves as a recruitment platform
that interacts with all TLS polymerases equally. Perhaps all the TLS polymerases are recruited to the
damage site randomly and attempt to replicate through the lesion. In this “trial-and-error” mechanism,
the “correct” polymerase bypasses a cognate lesion with the lowest energy expenditure. Non-ideal TLS
polymerases would only perform a bypass when the “correct” polymerase is unavailable. Therefore,
it might be the nature of the lesion itself that determines which polymerase engages and replicates
across a specific type of DNA damage.
5. Template Switching
The Template Switching branch of PRR enables the stalled replication fork to use the newly
synthesized daughter strand as template to avoid damaged DNA (Figure 3). Similar to TLS,
TS is also mediated by PCNA post-translational modifications, specifically poly-ubiquitination and
SUMOylation. The extension of Rad18-induced K164 mono-ubiquitination to poly-ubiquitination by
Ubc13-Mms2 and Rad5 redirects the PRR mode to TS.
Most of our understanding of TS was generated from a series of elegant studies in yeast, which
provided the basis for the existence of an error-free form of PRR [69,70]. This error-free mechanism
requires Rad5 [71,72], Ubc13/Mms2 [73,74], DNA Pol δ [75], a subset of the RAD52 epistasis group [76]
and involves recombination between partially replicated sister strands [77]. A groundbreaking study
by Branzei and colleagues combining 2D gel electrophoresis of DNA replication intermediates and
yeast genetics identified TS intermediates and defined their relationship with the previously mentioned
TS factors [78].
Template switching, involves the formation of an X-shaped recombination intermediate
like structure consisting of sister chromatic junctions (SCJs) close to the stalled replication fork.
SCJ formation requires Rad51 and the resolution of SCJs structures depends on the Sgs1 helicase [78].
The SCJs generated during TS resemble the properties of a DNA crossover intermediate in
homologous recombination [79]. A recent study visualized the recombination intermediates using
electron microscopy and proved that the undamaged sister chromatid is used as template using a
recombination-based mechanism [80]. During TS, the ssDNA template containing the DNA lesion
anneals with the newly synthesized double stranded sister chromatid to form a three-strand duplex.
This intermediate then releases the newly synthesized, undamaged daughter strand from the parental
strand so that it can be used as template for damage avoidance. The structures formed in this process
are later resolved by the Sgs1-Top3-Rim1 complex [80]. In addition to the core TS participants such as
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Rad5, Rad51, and Sgs1, there is a growing body of evidence that other DNA replication and damage
repair factors are also involved in TS. For example, the 9-1-1 complex and Exo1 nuclease are essential
for the initiation of TS [81], and Ctf4 was found to establish the connection between Pol α/primase
and the MCM helicase to protect the replication fork structure that favors TS [82].
Although Ubc13-Mms2 and Rad5-mediated poly-ubiquitination of PCNA at K164 is a crucial
event in TS, the structure and function of the PCNA poly-ubiquitin chain formed during TS remains
elusive. In contrast, the significance of PCNA SUMOylation has been studied in more detail and is
better understood. PCNA SUMOylation occurs both during normal, unperturbed DNA replication
and in response to DNA damage [14,15]. SUMOylated PCNA provides an interaction platform for the
recruitment of the Srs2 helicase [47,48]. Similar to other PCNA-interacting proteins, Srs2 contains a
non-canonical PIP box motif that mediates PCNA binding. However, the interaction between the Srs2
PIP box and PCNA is fairly weak until a second interaction is established between SUMOylated PCNA
and a SUMO-interacting motif at the C terminus of Srs2 [83]. PCNA-bound Srs2 helicase functions as a
safeguard that limits unscheduled recombination at the replication fork by disrupting Rad51 filament
formation on ssDNA during normal replication [84,85]. A small controversy still exists regarding why
PCNA SUMOylation is required for the TS pathway; Srs2 actively removes Rad51 from the replication
fork while template switching requires Rad51 activity. For this reason, it is generally believed that
SUMOylation antagonizes the effect of PCNA ubiquitination and inhibits the TS pathway [14,15].
A recent study may help resolve this paradox; a SUMO-like domain protein, Esc2, was found to
be recruited to stalled replication forks and displace Srs2, thereby creating a microenvironment that is
permissive for Rad51 chromatin-binding [86]. Therefore, PCNA SUMOylation facilitates the usage of
PRR on a challenged replication fork by suppressing homologous recombination. When TS is initiated
by PCNA poly-ubiquitination, replication fork binding factors such as Esc2 alleviate the inhibition of
recombination by PCNA SUMOylation and allow DNA damage avoidance [47].
Error-free DNA damage avoidance is a conserved PRR mechanism in metazoans [43,87]. Although
the identity of the human Srs2 orthologue is still being debated, human PCNA SUMOylation
has also been shown to suppress unscheduled DNA recombination via PARI (PCNA-associated
recombination inhibitor), suggesting a conserved mechanism of regulating HR at the replication
fork [88–90]. PCNA is also poly-ubiquitinated in human cells in response to DNA damage. Blocking
K63 linked poly-ubiquitination chain formation sensitizes cells to DNA damage, increases UV-induced
mutagenesis, and increases the reliance of cells on TLS for DNA damage tolerance [43]. Rad5
has evolved into two orthologues, SHPRH [38,39] and HLTF, in higher organisms [40,41]. Both
SHPRH and HLTF can poly-ubiquitinate PCNA in vitro but via distinct mechanisms. SHPRH extends
Rad18 mediated PCNA mono-ubiquitination, while HLTF transfers the pre-assembled poly-ubiquitin
chain to Rad6-Rad18 and eventually onto unmodified PCNA [38,39,91]. Depletion of SHPRH
and HLTF sensitizes the cell to DNA damaging agents and reduces PCNA poly-ubiquitination;
however, SHPRH−/−HLTF−/− double knockout mouse embryonic fibroblasts are still able to
poly-ubiquitinate PCNA, suggesting that other Rad5 orthologues might exist in higher organisms [92].
In addition to poly-ubiquitination of PCNA, HLTF has acquired additional functions in DNA damage
tolerance. In response to UV damage, HLTF is able to mono-ubiquitinate PCNA and promote Pol η
recruitment [93]. Furthermore, HLTF can also facilitate DNA strand invasion and D-loop formation in
a Rad51-independent manner [94].
In addition to TS, there are other recombination-based mechanisms, such as complementary
strand transfer repair (CSTR) [95] and replication fork reversal [96–99], that have also been shown to
contribute to DNA damage avoidance.
6. Timing of Post Replication Repair
Both major modes of PRR are used to cope with collisions between DNA polymerases and lesions
on the single-stranded DNA template. For this reason, PRR is critically important during S-phase
of the cell cycle, when the DNA duplex is unwound and vulnerable to injury. In fact, cells have
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developed sophisticated mechanisms to control the timing of DNA post replication repair by limiting
the availability of crucial PRR factors [100–102]. Interestingly, two studies using temporally controlled
expression of Rad18 or Pol η found that it is possible to delay the onset of PRR without significantly
affecting cell viability. Moreover, limiting PRR in the G2/M phase of the cell cycle does not significantly
delay the progression of the S-phase [103,104]. These studies suggest that it is possible to detach the
PRR with bulk DNA synthesis in the S-phase without compromising its function.
Nevertheless, the delayed onset of PRR during S-phase could potentially lead to the accumulation
of dangerously long and fragile ssDNA stretches, especially on the leading strand. Exposed ssDNA in
cells is frequently observed when the replicative polymerase is blocked. However, these ssDNA gaps
are usually small in size and are located inside a single replicon, regardless of whether they are on
the leading or the lagging strand. However extremely long ssDNA gaps (>3 kb) are rarely observed.
This suggests that the leading strand is also synthesized discontinuously when replicating a damaged
DNA template, similar to the discontinuous synthesis of the lagging strand [105].
Restart of replication requires a de-novo re-priming mechanism downstream (3′) of the stalled
leading strand DNA polymerase. This repriming activity is carried out by DnaG in E. coli [106], and
by a specialized polymerase PrimPol in higher organisms [107–110]. This repriming mechanism of
PRR explains why UV-induced lesions only cause a slight reduction in fork speed even when Pol η
is mutated in human cells [111]. The ability of PRR to function distal (5′) to a newly-primed leading
strand may provide ample time to select the optimal DNA damage tolerance mechanism. It is also well
established that TLS is functional outside the S phase of the cell cycle and can patch ssDNA arising in
the G0 and G1 phases [112–114].
7. Conclusions and Outlook
Although neither TLS nor TS directly repair DNA damage, both PRR mechanisms enable
an immediate response to polymerase stalling DNA lesions. PRR during S phase prevents gross
chromosomal rearrangements and ensures that replication is completed in a timely manner.
A deficiency in PRR could lead to replication fork collapse and the accumulation of DNA DSBs.
In the absence of PRR, DSB repair mechanisms could allow for tolerance of replication-associated
DNA damage. However, DSB repair pathways have limitations; DNA end-joining frequently results
in mutations, while HR serves as the salvage pathway and creates complex and unstable repair
intermediates through the use of a homologous strand from another DNA molecule. (For more insight
into salvage and other homologous recombination-mediated DNA damage tolerance, we invite readers
to read a recent review on this topic [115]) Therefore, PRR is perhaps the least genome-destabilizing
option for the tolerance of DNA lesions arising in S-phase.
Both branches of PRR are important for cells to tolerate and survive DNA damage. In terms of
maintaining genome stability, TS has a great advantage over TLS because it does not induce base
mutations. Because of its intrinsic error-propensity, TLS has been linked to both increased mutation
rates and might, therefore, fuel carcinogenesis [116–118]. In established cancers, TLS is also suggested
to be responsible for a high mutation frequency and elevated treatment resistance [116,119,120].
However, it is not known why untransformed cells would utilize the error-prone TLS pathway when
error-free TS is available.
Many DNA damaging chemotherapy agents cause lesions that can be tolerated by PRR. Such
lesions include bulky adducts generated by alkylating agents and the DNA crosslinks produced by
platinating agents. For this reason, cancer cells could upregulate PRR to survive therapy-induced DNA
damage. Interestingly, a recent report identified a cancer cell-specific mechanism of TLS activation that
might provide a general paradigm for how tumors acquire both mutability and DNA damage tolerance
via pathological PRR [121]. Therefore, targeting PRR pathways individually, or in combination
with compensatory genome maintenance mechanisms, could sensitize cancer cells to intrinsic and
therapy-induced replicative stress.
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